Global Nevirapine Market

Nevirapine Comprehensive Study by Type (100 mg, 200 mg, 400 mg), Application (Women (Pregnant, Non- pregnant), Men), Method (Antiretroviral Therapy, Hepatotoxicity) Players and Region - Global Market Outlook to 2023

Nevirapine Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Nevirapine Market Overview:
Nevirapine is an anti-HIV drug that reduces the amount of virus in the body. Nevirapine market is expected to mark significant growth over forecasted period owing infected patients with HIV at the time of birth and infection through breastfeeding also. There has been significant rise in number of infected with HIV at the time birth with figure stood up to 69 000 infants out of 1.1 millions in South Africa alone in 2018, the future for requirement of Nevirapine drugs looks promising.. This result in lack of awareness among people, increasing demand of nevirapine, and intrapartum risk factors for transmission may trigger demand and help in industry expansion.

Market Drivers
  • Increase in Demand of Neviraprine to Control the HIV Infections.
  • Rapid Demand of Neviprine Sustains Advantages over AZT During Breast Feeding Period Fuelled the Growth of Market.

Market Trend
  • The nevirapine drugs are mostly applicable in born children.

Restraints
  • Side Effects Associated with Nevirapine Drugs.
  • High Cost related to manufacturing of Nevirapine Drugs.

Opportunities
  • Research and Development took Place to Grow the Nevirapine Market.
  • Upsurge Application of Nevirapine Drugs in Developed Countries.

Challenges
  • Lack of Awareness Among Developing Countries Anticipated to Challenge the Market.


Competitive Landscape:

Some of the key players profiled in the report are Exxonmobil Chemical (United States), Eastman (United States), Heyun Group (China), RuiWeng Chemical (China), Chemiway (Japan), Kolonindustries (South Korea), Aurobindo Pharma (India) and Cipla (India). Additionally, following companies can also be profiled that are part of our coverage like Mylan Laboratories Ltd (United States), Lupin (India) and Ranbaxy Laboratories Limited (India). Analyst at AdvanceMarketAnalytics see United States Players to retain maximum share of Global Nevirapine market by 2023. Considering Market by Method, the sub-segment i.e. Antiretroviral Therapy will boost the Nevirapine market.

Market Highlights:

In December 2018, Cipla recall 4,800 bottles of anti- HIV tablets for treatment of human immunodeficiency virus (HIV) which is beneficial in expansion of business in US market.

“According to Food and Drugs Administration approved drug labels may be available for nevirapine. AIDSinfo provides the following drug label solely as an example of the labels available for nevirapine. Inclusion or absence of a drug label on the AIDSinfo site does not imply endorsement or lack thereof by AIDS information. Search Drugs for FDA to access more information on nevirapine, including additional drug labels and any generic equivalents.”

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Nevirapine market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Nevirapine market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Nevirapine Manufacturers, Nevirapine Traders, End-Use Market Participants of Different Segments of Nevirapine, Government and Research Organizations, R&D Institutions and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • 100 mg
  • 200 mg
  • 400 mg
By Application
  • Women (Pregnant, Non- pregnant)
  • Men
By Method
  • Antiretroviral Therapy
  • Hepatotoxicity

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in Demand of Neviraprine to Control the HIV Infections.
      • 3.2.2. Rapid Demand of Neviprine Sustains Advantages over AZT During Breast Feeding Period Fuelled the Growth of Market.
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness Among Developing Countries Anticipated to Challenge the Market.
    • 3.4. Market Trends
      • 3.4.1. The nevirapine drugs are mostly applicable in born children.
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
  • 5. Global Nevirapine, by Type, Application, Method and Region (value and price ) (2012-2017)
    • 5.1. Introduction
    • 5.2. Global Nevirapine (Price)
      • 5.2.1. Global Nevirapine by: Type (Price)
  • 6. Nevirapine: Manufacturers/Players Analysis
    • 6.1. Company Profile
      • 6.1.1. Exxonmobil Chemical (United States)
        • 6.1.1.1. Business Overview
        • 6.1.1.2. Products/Services Offerings
        • 6.1.1.3. Financial Analysis
        • 6.1.1.4. SWOT Analysis
      • 6.1.2. Eastman (United States)
        • 6.1.2.1. Business Overview
        • 6.1.2.2. Products/Services Offerings
        • 6.1.2.3. Financial Analysis
        • 6.1.2.4. SWOT Analysis
      • 6.1.3. Heyun Group (China)
        • 6.1.3.1. Business Overview
        • 6.1.3.2. Products/Services Offerings
        • 6.1.3.3. Financial Analysis
        • 6.1.3.4. SWOT Analysis
      • 6.1.4. RuiWeng Chemical (China)
        • 6.1.4.1. Business Overview
        • 6.1.4.2. Products/Services Offerings
        • 6.1.4.3. Financial Analysis
        • 6.1.4.4. SWOT Analysis
      • 6.1.5. Chemiway (Japan)
        • 6.1.5.1. Business Overview
        • 6.1.5.2. Products/Services Offerings
        • 6.1.5.3. Financial Analysis
        • 6.1.5.4. SWOT Analysis
      • 6.1.6. Kolonindustries (South Korea)
        • 6.1.6.1. Business Overview
        • 6.1.6.2. Products/Services Offerings
        • 6.1.6.3. Financial Analysis
        • 6.1.6.4. SWOT Analysis
      • 6.1.7. Aurobindo Pharma (India)
        • 6.1.7.1. Business Overview
        • 6.1.7.2. Products/Services Offerings
        • 6.1.7.3. Financial Analysis
        • 6.1.7.4. SWOT Analysis
      • 6.1.8. Cipla (India)
        • 6.1.8.1. Business Overview
        • 6.1.8.2. Products/Services Offerings
        • 6.1.8.3. Financial Analysis
        • 6.1.8.4. SWOT Analysis
  • 7. Global Nevirapine Sale, by Type, Application, Method and Region (value and price ) (2018-2023)
    • 7.1. Introduction
    • 7.2. Global Nevirapine (Price)
      • 7.2.1. Global Nevirapine by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Nevirapine: by Type(USD/Units)
  • Table 2. Company Basic Information, Sales Area and Its Competitors
  • Table 3. Company Basic Information, Sales Area and Its Competitors
  • Table 4. Company Basic Information, Sales Area and Its Competitors
  • Table 5. Company Basic Information, Sales Area and Its Competitors
  • Table 6. Company Basic Information, Sales Area and Its Competitors
  • Table 7. Company Basic Information, Sales Area and Its Competitors
  • Table 8. Company Basic Information, Sales Area and Its Competitors
  • Table 9. Company Basic Information, Sales Area and Its Competitors
  • Table 10. Nevirapine: by Type(USD/Units)
  • Table 11. Research Programs/Design for This Report
  • Table 12. Key Data Information from Secondary Sources
  • Table 13. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Nevirapine: by Type USD/Units (2012-2017)
  • Figure 5. Exxonmobil Chemical (United States) Revenue, Net Income and Gross profit
  • Figure 6. Exxonmobil Chemical (United States) Revenue: by Geography 2017
  • Figure 7. Eastman (United States) Revenue, Net Income and Gross profit
  • Figure 8. Eastman (United States) Revenue: by Geography 2017
  • Figure 9. Heyun Group (China) Revenue, Net Income and Gross profit
  • Figure 10. Heyun Group (China) Revenue: by Geography 2017
  • Figure 11. RuiWeng Chemical (China) Revenue, Net Income and Gross profit
  • Figure 12. RuiWeng Chemical (China) Revenue: by Geography 2017
  • Figure 13. Chemiway (Japan) Revenue, Net Income and Gross profit
  • Figure 14. Chemiway (Japan) Revenue: by Geography 2017
  • Figure 15. Kolonindustries (South Korea) Revenue, Net Income and Gross profit
  • Figure 16. Kolonindustries (South Korea) Revenue: by Geography 2017
  • Figure 17. Aurobindo Pharma (India) Revenue, Net Income and Gross profit
  • Figure 18. Aurobindo Pharma (India) Revenue: by Geography 2017
  • Figure 19. Cipla (India) Revenue, Net Income and Gross profit
  • Figure 20. Cipla (India) Revenue: by Geography 2017
  • Figure 21. Global Nevirapine: by Type USD/Units (2018-2023)
List of companies from research coverage that are profiled in the study
  • Exxonmobil Chemical (United States)
  • Eastman (United States)
  • Heyun Group (China)
  • RuiWeng Chemical (China)
  • Chemiway (Japan)
  • Kolonindustries (South Korea)
  • Aurobindo Pharma (India)
  • Cipla (India)
Additional players considered in the study are as follows:
Mylan Laboratories Ltd (United States) , Lupin (India) , Ranbaxy Laboratories Limited (India)
Select User Access Type

Key Highlights of Report


Jun 2019 225 Pages 84 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Nevirapine Market Quantitative research analysis
Global Nevirapine Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Nevirapine Market Report?

Have a Query? Click Here

Other Related Reports

Medication Adherence Packaging Systems Comprehensive Study by Type (Unit-dose Packaging Systems, Multi-dose Packaging Systems), Packaging (Ampoules, Vials, Prefilled Syringes & Injectable, Blisters, ...
$ 3750
Osteoarthritis Pain Drugs Comprehensive Study by Type (Oral, Injection, External), Application (Medical Care, Personal Care), Therapies (Non- Pharmacological Therapy, Pharmacological Therapy, Surgica...
$ 3750
Docusate Sodium Comprehensive Study by Type (DSS 100%, DSS 85%, DSS 50%), Application (Exicipient, Active Pharmaceutical Ingredients, Constipation, Pesticide adjuvant, Micelle encapsulation), Route o...
$ 3650
Resistant Maltodextrin Comprehensive Study by Type (Corn-based, Wheat-based, Others), Application (Beverages, Bakery & Confectionery, Dairy Products, Nutraceuticals, Others) Players and Region - Glob...
$ 3500
Lansoprazole Comprehensive Study by Type (Capsules, OD Tablet, Injection), Application (Male, Female), Distribution Channel (Hospital pharmacies, Online pharmacies, Retail pharmacies, Drug stores), R...
$ 3350
Hair Loss and Growth Devices Comprehensive Study by Type (Lasers, LED, Others), Application (Homecare, Hair Loss Treatment Clinic), Gender (Men, Women) Players and Region - Global Market Outlook to 2...
$ 3500